Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chana Palmer

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Plos Medicine|July 29, 2009
The preclinical natural history of serous ovarian cancer: defining the target for early detectionPatrick O Brown, Chana Palmer
Plos One|December 7, 2007
Mutation analysis of BRAF, MEK1 and MEK2 in 15 ovarian cancer cell lines: implications for therapyAnne L Estep, Chana Palmer, Frank McCormick, et al.
BMC Genomics|May 18, 2006
Cell-type specific gene expression profiles of leukocytes in human peripheral bloodChana Palmer, Maximilian Diehn, Ash A Alizadeh, et al.
American Journal of Medical Genetics. Part A|February 26, 2004
Analysis of neurofibromatosis 1 (NF1) lesions by body segmentChana Palmer, Jacek Szudek, Harry Joe, et al.
Plos Biology|June 28, 2007
Development of the human infant intestinal microbiotaChana Palmer, Elisabeth M Bik, Daniel B DiGiulio, et al.
Nucleic Acids Research|January 13, 2006
Rapid quantitative profiling of complex microbial populationsChana Palmer, Elisabeth M Bik, Michael B Eisen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2008
Ovarian cancer early detection claims are biasedMartin McIntosh, Garnet Anderson, Charles Drescher, et al.
Plos One|February 25, 2010
DNA methylation profiles of ovarian epithelial carcinoma tumors and cell linesSahar Houshdaran, Sarah Hawley, Chana Palmer, et al.
Plos One|July 10, 2008
Systematic evaluation of candidate blood markers for detecting ovarian cancerChana Palmer, Xiaobo Duan, Sarah Hawley, et al.
Plos Medicine|December 5, 2008
Ovarian carcinoma subtypes are different diseases: implications for biomarker studiesMartin Köbel, Steve E Kalloger, Niki Boyd, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos Medicine|July 29, 2009
The preclinical natural history of serous ovarian cancer: defining the target for early detectionPatrick O Brown, Chana Palmer
Plos One|December 7, 2007
Mutation analysis of BRAF, MEK1 and MEK2 in 15 ovarian cancer cell lines: implications for therapyAnne L Estep, Chana Palmer, Frank McCormick, et al.
BMC Genomics|May 18, 2006
Cell-type specific gene expression profiles of leukocytes in human peripheral bloodChana Palmer, Maximilian Diehn, Ash A Alizadeh, et al.
American Journal of Medical Genetics. Part A|February 26, 2004
Analysis of neurofibromatosis 1 (NF1) lesions by body segmentChana Palmer, Jacek Szudek, Harry Joe, et al.
Plos Biology|June 28, 2007
Development of the human infant intestinal microbiotaChana Palmer, Elisabeth M Bik, Daniel B DiGiulio, et al.
Nucleic Acids Research|January 13, 2006
Rapid quantitative profiling of complex microbial populationsChana Palmer, Elisabeth M Bik, Michael B Eisen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2008
Ovarian cancer early detection claims are biasedMartin McIntosh, Garnet Anderson, Charles Drescher, et al.
Plos One|February 25, 2010
DNA methylation profiles of ovarian epithelial carcinoma tumors and cell linesSahar Houshdaran, Sarah Hawley, Chana Palmer, et al.
Plos One|July 10, 2008
Systematic evaluation of candidate blood markers for detecting ovarian cancerChana Palmer, Xiaobo Duan, Sarah Hawley, et al.
Plos Medicine|December 5, 2008
Ovarian carcinoma subtypes are different diseases: implications for biomarker studiesMartin Köbel, Steve E Kalloger, Niki Boyd, et al.
Pageof 1